- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07589673
Development and Evaluation of an Online Shared Decision-Making Educational Program for Nurses and Patients With Chronic Diseases
May 21, 2026 updated by: Myonghwa Park, Chungnam National University
This study aims to develop and evaluate an online shared decision-making (SDM) educational program for nurses and patients with chronic diseases.
Shared decision-making is a process in which healthcare professionals and patients make health-related decisions together based on the best available evidence and the patient's values and preferences.
The study includes an evaluation phase.
In the evaluation phase, the program will be tested among nurses working in general hospitals and adults with chronic diseases living in the community.
Outcomes related to shared decision-making will be assessed at baseline, immediately after the 4-week program, and 1 month later.
The study is expected to improve shared decision-making competence, experience, and preparedness among both nurses and patients.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Shared decision-making is a key component of patient-centered care and is particularly important in chronic disease management, where patients often face repeated decisions about treatment options, symptom management, lifestyle modification, and long-term care.
Effective shared decision-making requires healthcare professionals and patients to exchange information, consider available options, and make decisions that reflect both clinical evidence and patient values and preferences.
Nurses play an important role in chronic disease care by providing education, coordinating communication, and supporting patient participation in health-related decision-making.
Patients with chronic diseases also need support to understand their options, clarify their values, and participate actively in decisions about their care.
However, structured educational opportunities to strengthen shared decision-making competence are limited for both nurses and patients.
This study will develop an online shared decision-making educational program for nurses and patients with chronic diseases and will evaluate its effectiveness in two parallel sub-studies.
For nurses, the study will be conducted as a cluster-randomized pretest-posttest controlled trial in general hospitals in Daejeon and Chungcheong-do, Republic of Korea.
Hospitals will serve as clusters, and one hospital will be assigned to the intervention group and the other to the control group by coin toss conducted by a third researcher who is not involved in study implementation or data analysis.
For patients with chronic diseases, the study will be conducted as a cluster-randomized pretest-posttest controlled trial in community health and welfare institutions.
Institutions will serve as clusters and will be assigned in a 1:1 ratio to intervention or control conditions using a computer-generated random allocation sequence prepared by a third researcher not involved in study implementation or data analysis.
The intervention will consist of a 4-week online SDM educational program delivered through a web-based platform.
Nurses in the intervention group will receive an online program consisting of 12 educational videos.
Patients in the intervention group will receive an online program consisting of 5 educational videos.
Control participants will receive comparison materials according to the study protocol.
Outcome measures will be collected at baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment.
The study will evaluate whether the program improves shared decision-making-related competence, experience, knowledge, decisional preparedness, and related outcomes in the two target populations.
Study Type
Interventional
Enrollment (Estimated)
288
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Geunyoung Lee
- Phone Number: +82 42-580-8407
- Email: lgy2513@gmail.com
Study Locations
-
-
-
Daejeon, South Korea, 35015
- Recruiting
- Chungnam National University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria for Nurse:
- Registered nurses currently providing direct patient care in participating general hospitals
- Able to understand the purpose and procedures of the study and provide informed consent
- Able to use a computer, tablet, or smartphone to access the online program
Exclusion Criteria for Nurse:
- Not currently engaged in direct patient care
- Unable to clearly express willingness to participate
- Unable to complete the educational program or questionnaires because of technical or language limitations
Inclusion Criteria for Patients:
- Adults aged 19 years or older living in the community
- Diagnosed with one or more chronic diseases requiring ongoing management, including but not limited to hypertension, diabetes mellitus, dyslipidemia, arthritis, chronic respiratory disease, or cardiovascular disease, with at least 3 months elapsed since diagnosis
- Able to understand the purpose and procedures of the study and provide informed consent
- Able to read and respond to survey questions
- Able to use a computer, tablet, or smartphone to access the online program
Exclusion Criteria for Patients:
- Cognitive impairment or communication problems that make participation difficult
- Unable to complete the educational program or questionnaires because of technical or language limitations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Online SDM Educational Program Group
Participants will receive access to a web-based shared decision-making educational program tailored for nurses or patients with chronic diseases for 4 weeks.
|
The nurse program is a 4-week web-based shared decision-making educational program for nurses working in general hospitals.
It is designed to enhance nurses' knowledge and skills in shared decision-making, decision support, and patient communication through self-directed online learning.
The patient program is a 4-week web-based shared decision-making educational program for adults with chronic diseases.
It is designed to support patients in participating in shared decision-making by helping them prepare for decisions, explore options, and clarify their values and preferences.
|
|
Active Comparator: Control Group
Participants will be provided access to publicly available comparison materials during the 4-week study period.
|
The control condition consists of access to publicly available communication-related educational materials, such as those provided by the Nursing Human Resources Employment Education Center.
The control condition consists of access to publicly available health management information, such as that provided by the National Health Information Portal.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in nurses' shared decision-making competence
Time Frame: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
Nurses' shared decision-making competence will be assessed using a shared decision-making competence scale for nurses.
The scale consists of 26 items with total scores ranging from 26 to 130. Higher scores indicate greater shared decision-making competence.
Changes in scores from baseline to each follow-up assessment will be compared between the intervention and control groups.
|
Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
|
Change in patients' shared decision-making experience
Time Frame: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
Patients' shared decision-making experience will be assessed using the Shared Decision-Making Questionnaire-9 items(SDM-Q-9).
The SDM-Q-9 consists of 9 items, with total raw scores ranging from 0 to 45. Higher scores indicate a greater level of patient-perceived shared decision-making.
Changes in scores from baseline to each follow-up assessment will be compared between the intervention and control groups.
|
Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in nurses' shared decision-making experience
Time Frame: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
Nurses' perceived shared decision-making practice will be assessed using the Shared Decision-Making Questionnaire-Physician version(SDM-Q-Doc).
The SDM-Q-Doc consists of 9 items, with total raw scores ranging from 0 to 45. Higher scores indicate a greater level of clinician-perceived shared decision-making.
Changes in scores across assessment points will be compared between the intervention and control groups.
|
Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
|
Change in patients' decisional conflict
Time Frame: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
Patients' decisional conflict will be assessed using the Decision Conflict Scale(DCS) Korean version.
Scores range from 0 to 100, with higher scores indicating greater decisional conflict.
Therefore, lower scores indicate a better outcome.
Changes in scores across assessment points will be compared between the intervention and control groups.
|
Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
|
Change in shared decision-making knowledge
Time Frame: Baseline and immediately after the 4-week intervention
|
Shared decision-making knowledge and understanding of the educational content will be assessed using pre- and post-program quizzes developed for each study population.
For nurses, the quiz consists of 24 items, and the number of correct answers will range from 0 to 24.
For patients, the quiz consists of 10 items, and the number of correct answers will range from 0 to 10.
A higher number of correct answers indicates greater knowledge and understanding of the educational content.
Changes in the number of correct answers from baseline to post-intervention will be compared between the intervention and control groups.
|
Baseline and immediately after the 4-week intervention
|
|
Preparation for decision making after the intervention
Time Frame: Immediately after the 4-week intervention and 1 month after the first post-intervention assessment
|
Preparation for decision making will be assessed using the Preparation for Decision Making(PrepDM), including the practitioner version for nurses and the participant version for patients, as applicable.
Scores range from 0 to 100, with higher scores indicating a higher perceived level of preparation for decision making.
Scores will be compared between the intervention and control groups after the intervention and at follow-up.
|
Immediately after the 4-week intervention and 1 month after the first post-intervention assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 10, 2026
Primary Completion (Estimated)
July 10, 2026
Study Completion (Estimated)
April 3, 2027
Study Registration Dates
First Submitted
May 10, 2026
First Submitted That Met QC Criteria
May 10, 2026
First Posted (Actual)
May 15, 2026
Study Record Updates
Last Update Posted (Actual)
May 26, 2026
Last Update Submitted That Met QC Criteria
May 21, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202511-SB-236-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsCompletedChronic Conditions, Multiple | Chronic ConditionDenmark
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
Radboud University Medical CenterCompleted
-
University of LimerickCompletedChronic Conditions, MultipleIreland
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on Online Shared Decision-Making Educational Program for Nurses
-
Xavier University of Louisiana.National Institute on Minority Health and Health Disparities (NIMHD); Tulane...CompletedProstate CancerUnited States
-
Radboud University Medical CenterCompleted
-
Dartmouth-Hitchcock Medical CenterUniversity of Maryland; University of Chicago; University of Pittsburgh; Brigham... and other collaboratorsCompleted
-
Maastricht University Medical CenterMaastricht UniversityEnrolling by invitationDiabetes Mellitus, Type 2Netherlands
-
Nemours Children's ClinicRecruitingSickle Cell DiseaseUnited States
-
Koç UniversityNot yet recruitingEvidence Based PracticeTurkey
-
Taipei Medical University WanFang HospitalNot yet recruitingAcute Kidney Injury | Emotional Dysfunction | Decision Making ,Shared
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Lisa RicharsonCompleted
-
CHU de Quebec-Universite LavalLaval University; Genome Canada; Genome Quebec; CERSSPLCompletedShared Decision MakingCanada